Evidence map›Paper›PMID 30222515›Full record

ArticleViral immunology2018

Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.

Keiko Nagata, Sayuri Hara, Yuji Nakayama, Katsumi Higaki, Hirotsugu Sugihara, Satoshi Kuwamoto, Michiko Matsushita, Masako Kato, Shunsuke Tanio, Kiyosuke Ishiguro and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Viral immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease.The Journal of clinical endocrinology and metabolism · 2021
    Article
  9. IgG4 as a Biomarker in Graves' Orbitopathy.Mediators of inflammation · 2021
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Keiko Nagata1 Division of Molecular Pathology, Department of Pathology, Faculty of Medicine, Tottori University , Yonago, Japan .
Sayuri Hara1 Division of Molecular Pathology, Department of Pathology, Faculty of Medicine, Tottori University , Yonago, Japan .
Yuji Nakayama2 Division of Functional Genomics, Research Center for Bioscience and Technology, Tottori University , Yonago, Japan .
Katsumi Higaki2 Division of Functional Genomics, Research Center for Bioscience and Technology, Tottori University , Yonago, Japan .
Hirotsugu Sugihara1 Division of Molecular Pathology, Department of Pathology, Faculty of Medicine, Tottori University , Yonago, Japan .
Satoshi Kuwamoto1 Division of Molecular Pathology, Department of Pathology, Faculty of Medicine, Tottori University , Yonago, Japan .
Michiko Matsushita3 Department of Pathobiological Science and Technology, School of Health Science, Faculty of Medicine, Tottori University , Yonago, Japan .
Masako Kato1 Division of Molecular Pathology, Department of Pathology, Faculty of Medicine, Tottori University , Yonago, Japan .
Shunsuke Tanio4 Division of Oral and Maxillofacial Biopathological Surgery, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University , Yonago, Japan .
Kiyosuke Ishiguro5 Division of Organ Regeneration Surgery, Department of Surgery, Faculty of Medicine, Tottori University , Yonago, Japan .
Kazuhiko Hayashi1 Division of Molecular Pathology, Department of Pathology, Faculty of Medicine, Tottori University , Yonago, Japan .
Tottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a newly recognized systemic fibroinflammatory disease with characteristic histological findings and high serum IgG4 levels. Epstein-Barr virus (EBV) is a persistent herpesvirus in B lymphocytes, and we previously reported EBV reactivation-induced Ig production. We showed that EBV reactivation induced the production of thyrotropin receptor antibodies, the causative antibodies of Graves' disease. In the present study, we investigated whether EBV reactivation induced IgG4 production and if EBV-positive B cells or IgG4-positive plasma cells are present in the thyroid tissues of Graves' disease patients with lymphoplasmacytic infiltration. EBV-encoded small RNA1 (EBER1) in situ hybridization and immunohistochemistry for IgG and IgG4 were performed on seven resected thyroid tissues with lymphoplasmacytic infiltration collected from the thyroids of 11 Graves' disease patients. We then cultured the lymphocytes of 13 Graves' disease patients and 14 controls and induced EBV reactivation to measure IgG4 levels in culture fluids. We detected EBER1-positive cells and IgG4-positive plasma cells in the same area of thyroid tissues. EBV-reactivated cells with IgG4 on their surface were observed in culture cells, and IgG4 production was detected in culture fluids. The IgG4/IgG percentage was higher than that in normal serum level. A subset of Graves' disease is an IgG4-RD-like condition, not an IgG4-RD. EBV reactivation stimulates IgG4 production, which may result in high serum IgG4 levels and promote IgG4-positive plasma cell infiltration. EBER1 needs to be examined when an increase in IgG4-positive plasma cell numbers is noted.

Indexed as

AdultAntibodies, ViralAutoimmune DiseasesB-LymphocytesCase-Control StudiesEpstein-Barr Virus InfectionsFemaleGraves DiseaseHerpesvirus 4, HumanHumansImmunoglobulin GMaleMiddle AgedRNA, ViralVirus ActivationYoung AdultAntibodies, ViralEpstein-Barr virus encoded RNA 1Immunoglobulin GRNA, ViralEpstein–Barr virusEpstein–Barr virus-encoded small RNA1Epstein–Barr virus reactivationGraves' diseaseIgG4-related disease

Identifiers

PMID30222515
PMCPMC6205085
OpenAlexW2891870896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.